SG Americas Securities’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-21,674
Closed -$155K 3759
2018
Q4
$155K Buy
+21,674
New +$241K ﹤0.01% 2507
2018
Q1
Sell
-1,515
Closed -$81K 3710
2017
Q4
$81K Buy
+1,515
New +$80K ﹤0.01% 2902
2016
Q4
Sell
-1,046
Closed -$134K 3634
2016
Q3
$134K Sell
1,046
-7,767
-88% -$994K ﹤0.01% 2829
2016
Q2
$1.1M Buy
+8,813
New +$1.01M 0.01% 1233
2015
Q4
Sell
-890
Closed -$109K 3115
2015
Q3
$109K Buy
+890
New +$121K ﹤0.01% 1825
2015
Q1
Sell
-670
Closed -$102K 3267
2014
Q4
$102K Buy
+670
New +$83.6K ﹤0.01% 2917
2013
Q4
Sell
-1,391
Closed -$224K 3196
2013
Q3
$224K Buy
1,391
+503
+57% +$79.2K ﹤0.01% 2108
2013
Q2
$118K Buy
+888
New +$125K ﹤0.01% 2016

Other funds holding ELGX

SG Americas Securities's ELGX Position: Q1 2019 in Review

SG Americas Securities sold out of Endologix Inc (ELGX) in Q1 2019, closing a stake of 21,674 shares — an estimated $155K sold.

SG Americas Securities first reported a position in ELGX in Q2 2013 and held it in 8 quarters. The position peaked at $1.1M in Q2 2016. 63 funds tracked by Wall St. Rank hold ELGX as of Q1 2019.

  • SG Americas Securities reported no remaining Endologix Inc position as of Q1 2019 after selling out during the quarter.
  • SG Americas Securities sold 21,674 Endologix Inc shares in Q1 2019, an estimated $155K.
  • SG Americas Securities first reported a position in Endologix Inc in Q2 2013 and held it in 8 quarters.
  • SG Americas Securities's Endologix Inc position peaked at $1.1M in Q2 2016.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2019.

Based on SG Americas Securities's 13F filing for Q1 2019, filed 29 Apr 2019.